Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;94(10):1466-8.
doi: 10.3324/haematol.2009.010702. Epub 2009 Jul 16.

Slow relapse in acute myeloid leukemia with inv(16) or t(16;16)

Thomas Clozel, Aline Renneville, Marion Venot, Claude Gardin, Charikleia Kelaidi, Geneviève Leroux, Virginie Eclache, Claude Preudhomme, Pierre Fenaux, Lionel Adès

Slow relapse in acute myeloid leukemia with inv(16) or t(16;16)

Thomas Clozel et al. Haematologica. 2009 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Minimal residual disease (MRD) sequentially measured by RQ-PCR in bone marrow samples in the 4 relapsing patients. MRD was expressed in CBFB-MYH11 copies per /100 ABL gene copies. Dots on curves represent MRD examinations. Full arrows indicate molecular relapse and empty arrows indicate hematologic relapse. Follow-up is in months.
See this image and copyright information in PMC

References

    1. Marcucci G, Mrózek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 23:5705–17. - PubMed
    1. Delaunay J, Vey N, Leblanc T, Fenaux P, Rigal-Huguet F, Witz F, et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood. 2003;102:462–9. - PubMed
    1. Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F, et al. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter “AIDA” trial. GIMEMA-AIEOP Multicenter “AIDA” Trial. Blood. 1998;92:784–9. - PubMed
    1. Cassinat B, de Botton S, Kelaidi C, Ades L, Zassadowski F, Guillemot I, et al. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group) Leuk Res. 2009;33:1178–82. - PubMed
    1. Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, et al. Quantitative real-time RT-PCR analysis of PML-RAR mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood. 2003;101:2521–8. - PubMed

Substances

LinkOut - more resources